Acetylated metabolite

Europe PMC · from cache · sorted by publication date

1. 1
   Gut microbial metabolism of Flutamide attenuates its therapeutic efficacy against prostate cancer.

   Li S, Ding H, Wang J, Yuan L, Zhou Y, Xu W, Yin H, Ye M, Sha Y, Li F, Liu Y, Zhu Z, Song L, Jin X, Ma L, Zhan… · 2026-06-07

   open access unreviewed
2. 2
   Impact of <i>N</i>-Acetylation on DNA Damage and Oxidative Stress Responses in Mammalian Cells and Human Hepatocytes Treated with Hydralazine.

   Habil MR, Stephens MA, Cass AA, Mittlestat EM, Kwon D, Ellison A, Kouokam JC, Hein DW. · 2026-04-10

   open access unreviewed
3. 3
   LC-QTOF-MS as a Tool for Quantitative and Qualitative Analysis of Isoniazid and Its Metabolites in Dog Liver Samples

   Horla J, Jajor P, Holumbiiovska T, Zhyla M, Vretsona N, Kotsyumbas G, Poźniak B. · 2026-02-01

   open access unreviewed
4. 4
   A plasma N-acetyl amino acid panel for type 2 diabetes discrimination built by targeted LC-MS/MS: A case-control study.

   Ding S, Xie Z, Chen D, Huang X, Wu Q, Zheng L, Xu S, Luo S. · 2026-06-03

   open access unreviewed
5. 5
   GNPS Feature-Based Molecular Networking as a Tool to Visualize Metabolic Toxicity from Drug-Drug Interactions: A Case Study with Methamphetamine and Ethanol.

   Kim M, Kim JH, Yoo SJ, Lee S. · 2026-01-02

   cited 1× open access unreviewed
6. 6
   N-acetyltransferase (NAT) 1 and NAT2 enzyme activities drive interindividual variability in sulfamethoxazole N-acetylation.

   Lanphier RM, Latham BD, Gerringer AJ, Interrante T, Jones CD, De Buysscher T, Fallon JK, Jackson KD. · 2025-11-01

   unreviewed
7. 7
   Lack of Genotoxic and Carcinogenic Potential for Nonsugar Sweeteners: A Review of Animal and Mechanistic Evidence.

   Marchitti SA, Boon D, Jack M, Goodman JE. · 2025-11-04

   cited 3× open access unreviewed
8. 8
   Fate and Removal of Antibiotics and Antibiotic Resistance Genes in a Rural Wastewater Treatment Plant: A Microbial Perspective of Nature-Based Versus Advanced Technologies.

   Brouwir L, KleinJan H, Balent C, Quabron G, Salmerón I, Venditti S, Gritten F. · 2025-11-24

   cited 3× open access unreviewed
9. 9
   Differentiation of Therapeutic and Illicit Drug Use via Metabolite Profiling.

   Stoeva-Grigorova S, Hvarchanova N, Gancheva S, Eftimov M, Georgiev KD, Radeva-Ilieva M. · 2025-11-17

   open access unreviewed
10. 10
    Removal of Toxic Metabolites-Chelation: Manganese Disorders.

    Vogt H, Kostakis GE, Purchase R, Spencer J, Tuschl K. · 2025-11-01

    cited 1× open access unreviewed

External claims. These come from an index outside this database and are not checked against it. Treat them as leads.